Comprehensive Slides on State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care

This slideset provides an overview of the latest data on ART safety and tolerability, emphasizing unique populations such as pregnant women, aging patients, populations with cardiometabolic toxicities, and transgender persons.
Jean Rene Anderson, MD
Jill Blumenthal, MD, MAS
Marta Boffito, MD, PhD, FRCP
Jennifer Cocohoba Headshot
Jennifer Cocohoba, PharmD
Joseph J. Eron, Jr., MD
Julian Falutz, MD, FRCPC
Eric K. Farmer, PharmD, BCPS, AAHIVP
Priscilla Y. Hsue, MD
Jens D. Lundgren, MD, DMSc
William R. Short, MD, MPH, AAHIVS
Darcy Wooten, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.16 MB
Released: November 28, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Dr Neha Pandit discusses barriers and solutions to PrEP uptake in key patient populations in this commentary from Clinical Care Options (CCO)

person default Neha Pandit, PharmD, AAHIVP, BCPS Released: December 2, 2022

Dr Monica Gandhi discusses key advances in HIV treatment over the past year, from Clinical Care Options (CCO)

Monica Gandhi, MD, MPH Released: December 2, 2022

A patient advocate discusses the importance of community-led HIV treatment and prevention, from Clinical Care Options (CCO)

person default Rena Janamnuaysook, MBA Released: December 2, 2022

Clinical Care Options (CCO) expert analysis of new data from IDWeek and HIV Glasgow 2022, provided by expert HIV faculty

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS Released: November 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings